Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism. [electronic resource]
Producer: 20171212Description: 19 p. digitalISSN:- 1756-8722
- Animals
- Cell Proliferation
- Down-Regulation
- Heterografts
- Humans
- Lung Neoplasms -- drug therapy
- MAP Kinase Signaling System
- Mesothelioma -- drug therapy
- Mesothelioma, Malignant
- Mice
- MicroRNAs -- genetics
- Peritoneal Neoplasms -- pathology
- Proto-Oncogene Proteins -- antagonists & inhibitors
- Proto-Oncogene Proteins c-akt -- metabolism
- Proto-Oncogene Proteins c-met -- antagonists & inhibitors
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Signal Transduction
- Axl Receptor Tyrosine Kinase
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.